2
项与 阿柏西普生物类似药(Rophibio) 相关的临床试验A Phase 3 Clinical Trial to Compare Efficacy, Safety, Tolerability and Immunogenicity of RBS-001 to Eylea® in Subjects with Neovascular Age-Related Macular Degeneration - PD-CP-Y1
A Phase 3 Clinical Trial to Compare Efficacy, Safety, Tolerability and Immunogenicity of RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration
This clinical study is designed to demonstrate the equivalence of the two Investigational Products by comparing the efficacy, safety, tolerability and immunogenicity of RBS-001 and Eylea® in subjects with Neovascular age-related macular degeneration.
100 项与 阿柏西普生物类似药(Rophibio) 相关的临床结果
100 项与 阿柏西普生物类似药(Rophibio) 相关的转化医学
100 项与 阿柏西普生物类似药(Rophibio) 相关的专利(医药)
100 项与 阿柏西普生物类似药(Rophibio) 相关的药物交易